These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7217176)

  • 1. Adverse reactions to intravenous contrast agents in Ontario, 1975 - 1979.
    Hobbs BB
    J Can Assoc Radiol; 1981 Mar; 32(1):8-10. PubMed ID: 7217176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and late adverse reactions to low-osmolal contrast media.
    Mikkonen R; Kontkanen T; Kivisaari L
    Acta Radiol; 1995 Jan; 36(1):72-6. PubMed ID: 7833173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous contrast media: use and associated mortality.
    Cashman JD; McCredie J; Henry DA
    Med J Aust; 1991 Nov; 155(9):618-23. PubMed ID: 1943961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective study of adverse reactions to contrast media administered intravenously--a comparison of low-osmolality and high-osmolality contrast media].
    Higashi S; Takizawa K; Suzuki S; Nagashima J; Tamura S; Ishikawa M; Obuchi M; Katayama M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1364-70. PubMed ID: 3237463
    [No Abstract]   [Full Text] [Related]  

  • 6. Reactions to contrast media according to injection time: incidence and clinical characteristics.
    Ayabe Z; Nishitani H; Onitsuka H; Baba H; Kawahira K; Uchino A; Matsuura K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Aug; 42(8):766-72. PubMed ID: 7155821
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to radiographic contrast material.
    Bush WH; Mullarkey MF; Webb DR
    West J Med; 1980 Feb; 132(2):95-8. PubMed ID: 7385829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
    Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
    Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and biological study of the immediate adverse reactions after the intravenous administration of organoiodate contrast substances. I. A clinico-statistical analysis].
    Păsculescu G; Dorca N; Baciu Z; Popa Luca I; Mihăilas R; Constantinescu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(1):75-8. PubMed ID: 2861640
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse reactions to intravenous pyelography contrast agents.
    Chodirker WB
    Can Med Assoc J; 1984 Feb; 130(4):343-4. PubMed ID: 6692222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and biological study of the immediate adverse reactions after the intravenous administration of organoiodate contrast substances. II. The behavior of enzyme systems in the serum].
    Păsculescu G; Chircoiaşu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(1):79-82. PubMed ID: 2861641
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse reactions to intravenous pyelography contrast agents.
    Hamilton G
    Can Med Assoc J; 1983 Sep; 129(5):405-6. PubMed ID: 6883227
    [No Abstract]   [Full Text] [Related]  

  • 13. Contrast-induced nephropathy after intravenous administration: fact or fiction?
    Katzberg RW; Lamba R
    Radiol Clin North Am; 2009 Sep; 47(5):789-800, v. PubMed ID: 19744594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Death following intravenous administration of Visotrast].
    Giebe W
    Z Arztl Fortbild (Jena); 1977 Jan; 71(1):40-2. PubMed ID: 855376
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders.
    Lang DM; Alpern MB; Visintainer PF; Smith ST
    Arch Intern Med; 1993 Sep; 153(17):2033-40. PubMed ID: 8102844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe adverse reactions to urography in patients taking beta-adrenergic blocking agents.
    Hamilton G
    Can Med Assoc J; 1985 Jul; 133(2):122. PubMed ID: 2408722
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of ultrasound contrast agents in stress echocardiography.
    Gabriel RS; Smyth YM; Menon V; Klein AL; Grimm RA; Thomas JD; Sabik EM
    Am J Cardiol; 2008 Nov; 102(9):1269-72. PubMed ID: 18940305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reactions to contrast media: rapid injection in 7,000 intravenous urographies].
    Girard JC
    J Radiol Electrol Med Nucl; 1975; 56 suppl 1():133-4. PubMed ID: 1232118
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of cases involving administration of contrast media during urography and cholangiography].
    Pol Przegl Radiol Med Nukl; 1971; 35(6):681-99. PubMed ID: 5142195
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactions to intravenous pyelography contrast media.
    Miller ES
    Radiol Technol; 1978; 50(3):269-73. PubMed ID: 264142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.